Join NPC at AMCP Nexus 2025 in National Harbor, MD!
NPC's research and leadership team will be participating at the AMCP Nexus 2025, October 28 - 30, 2025 in National Harbor, MD. In addition to the sessions below, NPC will present research posters, host a student networking reception, and more. Stay tuned for additional information!
Tuesday, October 28
Education Session: Unlocking the Value of Patient-Centered Research for Payer Decision Making | 3:15 – 4:30 PM ET
NPC's Kimberly Westrich will join Jennifer L. Bright, President and CEO of the International Consortium for Health Outcomes Measurement and Sarah E. Daugherty, Principal Scientist at Carelon Research for the panel "Unlocking the Value of Patient-Centered Research for Payer Decision Making."
Student and New Practitioner Networking Event | 5:30 – 6:30 PM ET
NPC will host a Student and New Practitioner Networking Event to offer students and early career practitioners an opportunity to network with established industry experts and researchers who will share advice, career opportunities, and life experiences.
Wednesday, October 29
Poster Presentation | 12:00 – 1:00 PM ET
NPC Research Manager Hanke Zheng will present findings from her team’s research titled “Does Delaying Coverage for Accelerated Approval Treatments Disproportionately Impact Patients With High Unmet Needs?”
Poster Presentation | 12:00 – 1:00 PM ET
Researchers from the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center will present research produced in partnership with NPC on “Assessing Commercial Health Plan Responsiveness to FDA Label Changes.”
Education Session: From Evidence to Implementation: Multi-Stakeholder Insights Into Innovative Contracting for Gene Therapies | 2:30 – 3:45 PM ET
NPC Director of Research Tyler Wagner will speak on a panel about “From Evidence to Implementation: Multi-Stakeholder Insights Into Innovative Contracting for Gene Therapies” alongside Alison Falb, Partner of Coral Health Advisors, Chronis Manolis, former Senior Vice President of Pharmacy for UPMC Health Plan, and Melissa Majerol, Model Lead of the Cell and Gene Therapy Access Model for the CMS Innovation Center.